# Helicobacter pylori infection and endothelial dysfunction

> **NIH NIH R01** · UNIVERSITY OF MISSOURI-COLUMBIA · 2021 · $658,722

## Abstract

Abstract
Recent studies have suggested an increased risk for atherosclerosis in patients with Helicobacter pylori (H.
pylori) infection. However, the mechanism(s) for increased risk for atherosclerosis with H. pylori infection is
currently unknown. It is well known that endothelial dysfunction plays a critical role in the development of
atherosclerosis and related cardiovascular diseases. The preliminary data for the project have shown that H.
pylori infection significantly impairs endothelium-dependent vasodilation in both patients and C57BL/6 mice.
Eradication of H. pylori infection in patients and mice significantly improves endothelium-dependent vascular
relaxation. Human endothelial cells cultured with serum exosomes from patients with H. pylori infection
exhibited significant dysfunction with decreased migration, proliferation, and tube formation in vitro. Exosomes
derived from conditioned media of human gastric epithelial cells cultured with H. pylori bacteria containing H.
pylori virulent factor cytotoxin-associated gene A (CagA) also significantly decreased endothelial functions
similar to serum exosomes. The present project is proposed to test the hypothesis that H. pylori infection
impairs endothelial function through exosome-mediated mechanism. The specific aims are: 1) to
investigate the effect of H. pylori infection on endothelial function; and 2) to define the role of
exosomes in mediating the effect of H. pylori infection on endothelial function. Since the vast majority of
patients with H. pylori infection are infected with the bacteria containing the virulence factor CagA, the mice
(C57BL/6 mice, both male and female) will be infected with CagA+ H. pylori for the proposed experiments. To
determine the effect of CagA protein on endothelial function, CagA- (negative) H. pylori will also be used to
repeat the in vitro and in vivo studies for comparison. Endothelial function will be determined in the mice
infected with either CagA+ or CagA- H. pylori with PBS as well as inactivated H. pylori as controls. To evaluate
the role of exosomes in mediating the effect of H. pylori infection on endothelial function in vivo, the animals
will be treated with GW4869 to decrease the release of exosomes from cells. If the hypothesis is true, it is
expected that endothelial function will be significantly decreased in the mice infected with either CagA+ or
CagA- H. pylori (more so with CagA+ H. pylori if CagA is important to H. pylori infection-induced endothelial
dysfunction). Inhibition of exosomes secretion with GW4869 is anticipated to effectively restore endothelial
function in mice with H. pylori infection. The data from the proposed study will provide novel insights into the
mechanisms for the development of vascular dysfunction in the patients with H. pylori infection, and help
explore new and effective strategies to preventing and treating cardiovascular diseases especially
atherosclerosis associated with H. pylori infection.

## Key facts

- **NIH application ID:** 10252889
- **Project number:** 5R01HL148196-03
- **Recipient organization:** UNIVERSITY OF MISSOURI-COLUMBIA
- **Principal Investigator:** ZHENGUO LIU
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $658,722
- **Award type:** 5
- **Project period:** 2019-08-15 → 2023-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10252889

## Citation

> US National Institutes of Health, RePORTER application 10252889, Helicobacter pylori infection and endothelial dysfunction (5R01HL148196-03). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10252889. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*